Boston Scientific — how they publish

10 posts · curated by ViralLoop

41 posts from @bostonsci, Jan 2024 to Jul 2025: a typical post earns 10 likes. That is more than 64% of the 275 other S&P 500 companies we hold content for. Posts with an image or video earn a median of 12 likes (29 posts); text alone 7 likes (12).

Boston Scientific@bostonsci

We’re excited to announce we have entered into a definitive agreement to acquire @axonics_mod and look forward to adding their devices used to treat urinary and bowel dysfunction to our Urology portfolio. t.co

Opens with an observation

Boston Scientific@bostonsci

We have officially closed the acquisition of @BoltIVL. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease. $BSX

Opens with an observation

Boston Scientific@bostonsci

We had the privilege of ringing the @NYSE closing bell in celebration of Boston Scientific’s 45th anniversary. This significant milestone honors our dedicated employees, the patients whose lives we’ve touched, and the global communities we’ve served. #BSX #AdvancingTogether

Opens with an observation

Boston Scientific@bostonsci

We’ve agreed to acquire @BoltIVL, developer of an intravascular lithotripsy (IVL) offering to treat coronary and peripheral disease, which will expand our cardiovascular portfolio with a complementary & differentiated calcium modification platform. t.co $BSX

Opens with an observation

Boston Scientific@bostonsci

Further expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension. t.co

Opens with an observation

Boston Scientific@bostonsci

We’ve entered into a definitive agreement to acquire @InteraOncology, a medical device company that provides a solution to treat metastatic colorectal cancer in the liver. Upon close, we look forward to welcoming the Intera Oncology team! t.co

Opens with an observation

Boston Scientific@bostonsci

We’ve entered into a definitive agreement to acquire @silkroadmed, a med tech co. focused on stroke prevention in patients with carotid artery disease through the TCAR procedure. Upon close, we look forward to welcoming the Silk Road team! t.co

Opens with an observation

Boston Scientific@bostonsci

We have officially closed the acquisition of @CortexEP. We look forward to advancing the OptiMap™ System developed by Cortex which complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex atrial fibrillation cases.

Opens with an observation

Boston Scientific@bostonsci

Our employees’ feedback on @Glassdoor has earned us the title of a Best Place to Work in 2024. #GlassdoorBPTW

Opens with an observation

Boston Scientific@bostonsci

Boston Scientific announces results for Q2 2025: t.co $BSX

Opens with a number